Immune biology of NSCLC revealed by single-cell technologies: implications for the development of biomarkers in patients treated with immunotherapy
Wlosik, J., Fattori, S., Rochigneux, P., Goncalves, A., Olive, D., Chretien, A. S.
Published in Seminars in immunopathology (01.01.2023)
Published in Seminars in immunopathology (01.01.2023)
Get full text
Journal Article
Using one-step nucleic acid amplification (OSNA) for intraoperative detection of lymph node metastasis in breast cancer patients avoids second surgery and accelerates initiation of adjuvant therapy
Klingler, S., Marchal, F., Rauch, P., Kenouchi, O., Chrétien, A.S., Genin, P., Leroux, A., Merlin, J.L.
Published in Annals of oncology (01.09.2013)
Published in Annals of oncology (01.09.2013)
Get full text
Journal Article
P421: LOWER VΓ9VΔ2 T CELLS RELATIVE FREQUENCIES PREDICT POORER SURVIVAL IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA
Le Floch, A.‐C., Orlanducci, F., Le Roy, A., Hamel, J.‐F., Ifrah, N., Cornillet‐Lefebvre, P., Delaunay, J., Récher, C., Delabesse, E., Pigneux, A., Béné, M.‐C., Vey, N., Chretien, A.‐S., Olive, D.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
P53 and PTEN expression contribute to the inhibition of EGFR downstream signaling pathway by cetuximab
Bouali, S, Chrétien, A-S, Ramacci, C, Rouyer, M, Marchal, S, Galenne, T, Juin, P, Becuwe, P, Merlin, J-L
Published in Cancer gene therapy (01.06.2009)
Published in Cancer gene therapy (01.06.2009)
Get full text
Journal Article
1058P Hyperprogressive disease during immune checkpoint inhibitor: A cloudy phenomenon with real consequences
Bruyat, D., Girard, N., Penel, N., Heudel, P-E., Gonçalves, A., Madroszyk Flandin, A-C., Gravis, G., Chanez, B., Collineau, B., Chrétien, A-S., Beaufils, M., Billon, E., Rochigneux, P.
Published in Annals of oncology (01.09.2024)
Published in Annals of oncology (01.09.2024)
Get full text
Journal Article
21P Mass cytometry reveals a population of exhausted CD8+ T cells associated with durvalumab/tremelimumab/vinorelbine efficacy in advanced cervical cancer (iMOVIE)
Bertucci, A., Maby, P., Rochigneux, P., Legrand, F., Cropet, C., Frenel, J-S., Le Tourneau, C., Hervieu, A., Coquan, E., De La Motte Rouge, T., Saada, E.B., Lavaud, P., Ben-Amara, A., Rouvière, M-S., Grassi, P., Gorvel, L., Goncalves, A., Olive, D., Chrétien, A-S.
Published in Immuno-oncology technology (01.12.2023)
Published in Immuno-oncology technology (01.12.2023)
Get full text
Journal Article